- Hospital margins lag as expense growth outpaces inflation: 5 notes
- Every safety event has a cultural backstory – The hidden cost of dominant leadership in healthcare
- Franciscan Alliance CEO to retire
- Fish Oil Supplements May Be A Bust For Alzheimer's Prevention
- Prehab Can Boost Seniors' Recuperation From Spinal Fusion Surgery, Trial Finds
- Ozempic Might Cut Risk Of Broken Bones, Study Says
- Dog Owners Feel Similar Grief Whether Pets Euthanized, Die Naturally
- Massage Guns Can Cause Eye Damage, Vision Loss, Case Report Warns
- Hiring, pay and restructuring: 4 HR leaders on difficult workforce decisions
- First free dental clinic opens in New Jersey
- The week in hospital M&A
- 5 dental insurance changes dentists need to know from the past 15 days
- A new medical school is opening nearby. What do health systems do first?
- ‘Snowbirds’ and ‘med-à-terres’: The market behaviors shaping systems’ growth decisions
- Indiana dental office manager sentenced to 36 months in prison for Medicaid fraud
- OpenAI says new ChatGPT model tops physician-written health answers
- CMS’ accreditation overhaul: What it means for hospitals
- Eli Lilly begins denying 340B discounts
- 5 cardiology leaders building the ASC ownership model
- What it actually takes to launch cardiac ablations in an ASC
- 5 federal, state legislative updates affecting the dental workforce
- How many dentists the largest DSOs support
- 8 new behavioral health projects to know
- Anesthesia has a usage problem not a workforce shortage, leaders say
- Remain or Reimagine: Free Interactive Tool Shows Dentists the value of remaining independent vs partnering with Elevate
- Pennsylvania dental group settles patient coverage lawsuit for $1M
- Pennsylvania physicians push back on consolidation with first-ever independent practice summit
- The ASC procedure list is growing — here’s what’s still missing
- wRVU pay, hospital subsidies don’t constitute Stark law fraud, court rules
- Specialty dentists’ compensation has climbed 39% since 2019
- ASCs’ block time hoarding problem
- Oregon prosecutors urge state to fix mental health system
- Arkansas lab pays $30M to settle kickback allegations tied to gastroenterology practices
- The case for layering behavioral healthcare models
- Why dentistry needs a revamp
- Rural, independent Kansas hospitals launch clinically integrated network
- Nova Southeastern launches 1st anesthesiologist assistant program in Nevada
- 12 behavioral health services, facility closures | 2026
- Higher, short-acting opioid doses linked to 8% lower discharge risk: 4 notes
- Cardiologists push back on CMS’ proposed pay policy changes
- 14,700 bottles of antidepressant recalled over impurity concerns
- FTC orders Aurobindo to divest 4 drugs to complete $250M Lannett acquisition
- Congressional Budget Office calls for more research on No Surprises Act unintended impacts
- 7 DSOs making headlines
- HHS opens applications for $700M in mental health, addiction funding, with $96M for new STREETS program
- Ebola Infections Climb, Could Take Year To Contain, Health Officials Say
- How Northwell is using paramedics to close behavioral healthcare gaps
- Feeling Sleepy During the Day? It Could Be a Warning Sign for High Blood Pressure
- FTC, states sue transgender health association over 'misleading' gender care guidance
- Healthcare organizations still struggle to operationalize AI at scale: Arcadia survey
- Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma
- Major League Pitchers Might Avoid Elbow Injuries By Altering Their Approach, Simulation Suggests
- Birth Control Pills Might Increase Binge Eating Risk, Study Finds
- Women Might Lower Their Heart Risk By Lifting Weights, Study Says
- Personalized Brain Implant Provides Step-By-Step Walking Boost For Parkinson's Patients
- Amid industry’s cell therapy automation push, Cellares and Ori dominate the field: report
- Most Americans Are Surviving Cancer. But The Mental Health Challenges Can Persist.
- Listen to the Latest ‘KFF Health News Minute’
- Readers Curse Medical Debt and Defend Spelling Therapy
- Arrests of Immigrant Parents Create Mental Health Crisis for Children
- Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources
- Novo's success with oral Wegovy has been fueled by 'familiarity': Spherix
- 20 new behavioral health study findings to know
- 31 behavioral health executive moves to know
- Centerstone names COO
- One Medical Seniors reports data breach of third-party vendor impacting 'limited' number of patients
- A look at Epic's long-term play to build tech for operations, starting with scheduling
- U.K. Moves To Ban Social Media For Children
- Pregnant Woman Exposed to 45 Common Chemicals, Study Finds
- OhioHealth reaches settlement with DOJ, Ohio AG on antitrust lawsuit
- 4 years after snub, GSK partnership helps Spero get Utebzi across FDA finish line
- Despite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancer
- OIG report raises red flags about maternal health 'ghost networks' in Medicaid managed care
- Lantern, Marathon Health team up to launch integrated care management model
- Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility
- Whoop, HealthEx partner to connect members’ medical records and biometric data
- GSK runs first DTC ad for would-be asthma blockbuster Exdensur
- Novo security breach claimed by hacking groups seeking multi-million-dollar ransoms: reports
- After FDA sign-off, Colorado's drug import plan faces tough road ahead
- Lower Risk Of Death, Clots Among Autoimmune Patients Taking GLP-1 Drugs
- Surgical Menopause Tied To Worse Sexual And Urinary Symptoms
- Post-Op Delirium Common In Seniors, But Not All Hospitals Screen For It
- Nortiva purrs into action with long-acting Lynx platform salvaged from Langer startup
- Why one life insurer is going big on health incentives
- Weekly Rundown: Lumeris adds symptom-checking tool to AI platform; DeepIntent rolls out agentic AI tool for healthcare marketers
- Early-Onset Cancers Are On The Rise. Knowing Your Family History Is Crucial.
- Minimally Invasive Procedure Eases Arthritis Knee Pain, Study Finds
- Tennessee Pharmacies Sell Potent Ivermectin, Led by Anti-Vaccine Doctor Who’s Taken ‘Bucketloads’
- More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.
- Democrats Seek To Spotlight Rising Health Costs by Forcing Vote on Trump Regulation
- Health services deal value holds steady in 2026 with higher bar for investment: PwC
- CMS tightens oversight of accreditation organizations, limits fee-based consulting
- MedPAC offers a look at enrollment hiccups for Medicare beneficiaries
- CDC, FDA Tackle New World Screwworm, Including Drug Authorization
- 'Biopharma ecosystem is back to full health,' fueled by M&A: PwC
- Lifestyle Changes Can Reduce Your Risk For Multiple Chronic Diseases
- US telehealth utilization climbs 10.1% in Q1, led by mental health visits: Fair Health
- FDA, UK drug regulator deepen transatlantic ties with new liaison program
- People Walk, Exercise Less After Starting Ozempic, Zepbound
- Family Finances Shape Children’s Brain Development, Study Finds
- At-Home Blood Pressure Monitoring Reduces Risk of Heart Attack, Stroke
- Moderna hires Novartis vet to lead commercial, upsizes role for Hoge as potential launches loom
- Uncovr secures $7M in seed funding for AI surgical documentation platform
- Long-Awaited Rule Aims To Boost ACA Choices While Embracing Higher Deductibles
- Many Men Are Prescribed Testosterone Without Proper Testing
- Early-Onset Cancers Are on the Rise. Knowing Your Family History Is Crucial.
- Backed by Threat of Clawbacks, Feds Wield Tight Grip on $50B Rural Health Fund
- Stealth BioTherapeutics removes cloak to become Mighty
- Recipharm channels ‘multi-million-dollar' US manufacturing upgrade, targeting domestic biologics demand
- DeepIntent gives Helix an AI twist to help marketers query data
- PhRMA talks up the power of ‘Medicines First’ in new campaign
- Centene offering staff buyouts as it navigates murky ACA waters
- KFF: Insurer participation in the ACA marketplaces declined from 2025 to 2026
- Organic Baby Formula Recalled Following Botulism Cases
- Germany backs off plan to install variable discount pricing on drugs: report
- Judge tosses multiple provisions of CMS' 2025 ACA program integrity rule
- FDA Approves First Over-the-Counter Glucose Monitor for Children, The Stelo Glucose Biosensor System
- You've Won The Game
- IQVIA taps AI to put overlooked prescribers on marketers’ maps
- Many Patients Stop And Restart GLP-1 Meds, Study Finds
- Merck's Welireg-Keytruda pairing sticks the landing in adjuvant kidney cancer treatment with new FDA nod
- Sanofi, once on FDA course for speedy approval, gains late expansion for Tzield
- Half Of U.S. Parents Track Their Adult Children’s Location
- Taking GLP-1s While On BP Meds May Up Your Risk Of Dizzy Spells, Fainting
- Trust In CDC Plummets Under Trump Administration, New Poll Shows
- Fentanyl Users Take Daily Doses 60 Times The Lethal Level
- Final Rules For Medicaid Work Requirements Are Out. Here's What You Need To Know.
- Long-Awaited Rule Aims To Boost ACA Choices While Embracing Higher Deductibles
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Influencers, Booze And Teens: What's Showing Up In Their Feeds?
- Health 'War Room,' Digital Tools Are Tracking Disease Risks During World Cup
- Food Labels and Restrictions Can Lower Childhood Obesity Rates, Study Finds
- Tourette Patients Face High Suicide Risk, Pain And Discrimination
- Have A Risk-Taking Teen? This Brain Chemical Might Be Responsible, Researchers Say
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- How lab data powers precision commercialization to drive therapy adoption
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
Michigan healthcare freedom community forum
It would appear that the "Hands Off My Medicare" crowd attacking RFK, Jr. and the Trump Administration have been waxing delusional:
https://www.fiercehealthcare.com/payers/cms-finalizes-506-medicare-advantage-benchmark-increase
CMS finalizes 5.06% Medicare Advantage benchmark increase
By Noah Tong - April 7, 2025The Centers for Medicare and Medicaid Services (CMS) finalized an increase of the average benchmark payments to Medicare Advantage (MA) plans by 5.06% on Monday.
It is nearly a three percentage-point increase over the advance notice proposed in the waning days of the Biden administration and will be seen as favorable to payers. CMS said this is due to the effective growth rate increase from 5.93% to 9.04% in the rate announcement.
“This change is primarily due to the inclusion of additional data on fee-for-service (FFS) expenditures, including payment data through the fourth quarter of 2024, which was not included on account of the early Advance Notice publication,” the agency said in a news release.
Rebasing and re-pricing ultimately brought the payments to plans down by approximately a quarter of a percent.
UnitedHealth Group stock increased by 6% in after-hours trading over its day-end closing price, following brutal days for the stock market because of tariff-induced challenges. CVS Health jumped by 9%, Elevance Health by 8% and Humana by 16%. Insurtechs Clover Health Alignment Healthcare increased by 6% and 9% respectively.
CMS will also finish phase-in of the MA risk adjustment model, and continue the phased-in approach for removing medical education costs from expenditures in growth rate calculations. Most insurers asked for the risk adjustment model to be paused.
The rate increase was supported by Medicare Advantage advocate Better Medicare Alliance and the Alliance for Community Health Plans (ACHP). The ACHP was one of the few insurer groups to support the new risk adjustment model and did not want it delayed.
"ACHP commends the Trump administration for finalizing policies in the [rate notice] that reflect higher care delivery costs and for taking another step toward reining in aggressive risk adjustment to boost competition," said President and CEO Ceci Connolly in a statement. "ACHP has long supported the new MA risk adjustment model and is pleased that CMS will finally complete the transition."
In January, CMS released the proposed rate, which would have increased payments by 2.23% and continued implementation of the risk adjustment model. Payments from the federal government would have increased by $21 billion, or 4.33%, the CMS said.
Doctors criticized the proposed rate, arguing insurers were once again receiving preferential treatment from the federal government. Providers and physicians said Congress still hasn't reversed painful doc pay cuts implemented by CMS as required by prior statute—and yet insurers were in line to get a boost.
The physician pay reversal was included in an end-of-the-year healthcare package before the bill failed at the eleventh hour due to other political considerations. It was again rejected in an effectively symbolic introduction by Senators Ron Wyden, D-Oregon and Bernie Sanders, I-Vermont before the Senate agreed to a government funding bill.
The insurance lobby criticized Biden’s health officials during his tenure for enacting tougher rates on plans, so the 2.23% rate was more favorable to payers than initially expected. In 2024, the government finalized a cut of 0.16% to MA plans.
Starting Jan. 1, annual out-of-pocket prescription drug costs were capped at $2,000 for enrollees.
CMS recently released its Contract Year 2026 MA and Part D final rule, choosing to punt on implementing agent and broker marketing requirements, most star ratings changes and imposing new guardrails on AI. The rule also declined to adopt a Biden-supported policy to have Medicare and Medicaid cover anti-obesity drugs, but did include new requirements on prior authorization and Special Supplemental Benefits for the Chronically Ill.
Left of center Morning Brew brings some additional macro market perspective.
https://www.healthcare-brew.com/stories/2025/04/09/cms-hikes-medicare-advantage-payments
CMS hikes Medicare Advantage payments up 5%, over $25b
Government payments to MA plans are set to rise over $25b in 2026—and Wall Street noticed.
By Caroline Catherman | April 9, 2025The federal government is going to pay Medicare Advantage (MA) plans a lot more in 2026.
In payment policy updates released on Monday evening, the Centers for Medicare and Medicaid Services (CMS) said MA plans will receive average payment increases of 5.06%—or more than $25 billion—from 2025 to 2026. This is 2.83 percentage points higher than CMS had predicted in its January advance notice of these changes, and more than double the 2.33% increase it had estimated from 2024 to 2025.
“This was the administration’s first chance to pump the brakes on MA, and there was some uncertainty going into the release. The rate notice indicates a desire to drive on—and maybe accelerate,” Luke Hansen, chief medical officer at Arcadia, a healthcare data platform for payers and providers, told Healthcare Brew.
For 2025, the Medicare Payment and Advisory Commission predicted the federal government will pay MA plans $538 billion. (In 2024, it paid $494 billion, per the commission.)
Though the stock market is largely a burning dumpster fire right now, MA providers’ shares are soaring after the news.
The largest MA provider, UnitedHealthcare, saw its stock jump from $524.70 at market close on Monday to $582.17 at market open on Tuesday, though the stock came down to around $553.08 by the day’s end.
Why so high? CMS said on April 7 that the rate increase is “largely attributable” to an increase in the effective growth rate. This rate represents the average expected change in MA benchmarks, which is the maximum amount the government will pay each Medicare Advantage plan, according to independent research nonprofit the Commonwealth Fund.
Benchmarks are calculated using the average spending in traditional fee-for-service Medicare in each county. That data wasn’t complete for 2024 when CMS estimated a 5.93% effective growth rate in its 2026 advance notice. Now, with the data complete, the effective growth rate is 9.04%, CMS said.
Zooming out. The rate updates and 2026 guidance were released just days after Congress approved Mehmet Oz as the new CMS director on April 3.
The New York Times reported in February that Oz has financial ties to Medicare Advantage companies, like TZ Insurance, sparking concerns about potential conflicts of interest. But during congressional confirmation hearings, Oz addressed bipartisan concerns about prior authorization and overpayment.
CMS will also in 2026 complete reforms to the MA risk adjustment model, which is intended to reduce overpayments, and finalize guidance on the Inflation Reduction Act’s Part D changes, including the Medicare Drug Price Negotiation Program.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.






















